Nalbuphine ointment（Lumosa Therapeutics）
癸二酸丁那布啡外用软膏（顺天医药生技）
Report date: 2026/03/30 17:02:26
Base Information
Drug NameNalbuphine ointment（Lumosa Therapeutics）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLumosa Therapeutics Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesLumosa Therapeutics Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A